ATARA Biotherapeutics (ATRA) Misses Q1 EPS by 29c

ATARA Biotherapeutics (NASDAQ: ATRA) reported Q1 EPS of ($0.29). Revenue for the quarter came in at $520 thousand.

For earnings history and earnings-related data on ATARA Biotherapeutics (ATRA) click here.

You May Also Be Interested In

• Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
• Home Depot (HD) PT Raised to $340 at Stifel Amid 'Sea Change in Investor Sentiment'
• Grocery Outlet Holding (GO) PT Raised to $11.50 at UBS